Table 3.
Issue | Average rating |
---|---|
Existence of a therapeutic indication or use during pregnancy | 4.5 |
Known low risk of teratogenicity | 4.3 |
Short washout period if withdrawn | 4.1 |
Positive data from DMD-exposed pregnancy | 3.7 |
Provision of a sufficient period of controlled disease to complete a pregnancy | 3.5 |
Existence of a therapeutic indication or use during lactation | 3.3 |
Positive data from breastfeeding women taking the DMD | 2.9 |
Experts allotted a score of 1 (low) to 5 (high) reflecting the importance of each issue as a driver of prescribing decisions for a woman of childbearing potential, and average scores for each issue are shown here.